STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Bausch + Lomb Will Release First-Quarter 2022 Financial Results on June 8

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags

Bausch + Lomb Corporation (NYSE/TSX: BLCO) will announce its first-quarter 2022 financial results on June 8, 2022, at 8:00 a.m. ET. A conference call and live webcast will follow to discuss the results and provide a business update. Materials will be available on the company's Investor Relations website before the call.

Founded in 1853, Bausch + Lomb focuses on eye health products, with a portfolio of over 400 products and a presence in nearly 100 countries.

Positive
  • Scheduled financial results announcement on June 8, 2022.
  • Comprehensive portfolio of over 400 eye health products.
Negative
  • None.

Insights

Analyzing...

VAUGHAN, Ontario, May 25, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter 2022 financial results on Wednesday, June 8, 2022. Bausch + Lomb will host a conference call and live web cast at 8:00 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call.

Conference Call Details

Date:

Wednesday, June 8 2022



Time:

8:00 a.m. ET



Webcast:

https://www.webcaster4.com/Webcast/Page/2883/45732 



Participant Event Dial-in: 

+1 (888) 506-0062 (North America)

+1 (973) 528-0011 (International)



Participant Access Code:

535779



Replay Dial-in:

+1 (877) 481-4010 (North America)

+1 (919) 882-2331 (International)



Replay Passcode:

45732 (replay available until June 22, 2022)

 

About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Twitter, LinkedIn, Facebook and Instagram.

© 2022 Bausch & Lomb Incorporated or its affiliates.

 

Investor Contacts:

Media Contacts:

Arthur Shannon

Lainie Keller

arthur.shannon@bauschhealth.com

lainie.keller@bauschhealth.com


(908) 927-1198

Allison Ryan


allison.ryan@bauschhealth.com

Kristy Marks

(877) 354-3705 (toll free)

kristy.marks@bausch.com

(908) 927-0735

(908) 927-0683

 

Bausch + Lomb (PRNewsfoto/Bausch + Lomb)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch--lomb-will-release-first-quarter-2022-financial-results-on-june-8-301554579.html

SOURCE Bausch + Lomb Corporation

FAQ

When will Bausch + Lomb release its Q1 2022 financial results?

Bausch + Lomb will release its Q1 2022 financial results on June 8, 2022.

What time is the Bausch + Lomb financial results conference call?

The conference call will take place at 8:00 a.m. ET on June 8, 2022.

Where can I find the materials for the Bausch + Lomb earnings call?

Materials will be available on the Investor Relations section of the Bausch + Lomb website before the call.

What stock symbol is associated with Bausch + Lomb?

The stock symbol for Bausch + Lomb is BLCO.
Bausch + Lomb Corporation

NYSE:BLCO

BLCO Rankings

BLCO Latest News

BLCO Latest SEC Filings

BLCO Stock Data

5.16B
38.52M
88.06%
11.29%
0.91%
Medical Instruments & Supplies
Ophthalmic Goods
Link
Canada
VAUGHAN